Figure 6.
Figure 6. Effect of repeated administration of the small compounds on peripheral blood cell levels in neutropenic CD rats. Male CD rats were injected intraperitoneally with 25 mg/kg CPA on day 0 (arrowhead), and thereafter treated subcutaneously with SSCL02446 nitrate (panel A), SSCL02447 nitrate (panel B), SSCL02448 nitrate (panel C), or rhG-CSF (panel D) on 4 consecutive days (days 1-4), and neutrophil counts were measured in peripheral blood. The arrows indicate the times of administration of small compounds and rhG-CSF. On day –2 and days 1, 2, 3, 4, 5, 6, and 8, peripheral blood cells were collected. On days 1, 2, 3, and 4, they were collected 8 hours after each administration. Each point represents the mean of counts on 4 or 5 rats ± SEM. Blood smears from each group were stained with Diff Quik, and differential counts were performed as described in “Materials and methods.” Significant differences (*P < .05; **P < .01) from vehicle control were assessed by Dunnett test.

Effect of repeated administration of the small compounds on peripheral blood cell levels in neutropenic CD rats. Male CD rats were injected intraperitoneally with 25 mg/kg CPA on day 0 (arrowhead), and thereafter treated subcutaneously with SSCL02446 nitrate (panel A), SSCL02447 nitrate (panel B), SSCL02448 nitrate (panel C), or rhG-CSF (panel D) on 4 consecutive days (days 1-4), and neutrophil counts were measured in peripheral blood. The arrows indicate the times of administration of small compounds and rhG-CSF. On day –2 and days 1, 2, 3, 4, 5, 6, and 8, peripheral blood cells were collected. On days 1, 2, 3, and 4, they were collected 8 hours after each administration. Each point represents the mean of counts on 4 or 5 rats ± SEM. Blood smears from each group were stained with Diff Quik, and differential counts were performed as described in “Materials and methods.” Significant differences (*P < .05; **P < .01) from vehicle control were assessed by Dunnett test.

Close Modal

or Create an Account

Close Modal
Close Modal